Reviva Pharmaceuticals Holdings, Inc.

USD

1.71

	Feb '20	Dec '20	Dec '21	Dec '22
revenue
cost of revenue		724.74K -
gross profit		-724.74K -
selling and marketing expenses
general and administrative expenses	181.12K -	2.14M 1,081.29%	5.25M 145.52%	5.36M 2.01%
selling general and administrative expenses	181.12K -	2.14M 1,081.29%	5.25M 145.52%	5.36M 2.01%
research and development expenses	195.74K -	295.15K 50.78%	4.85M 1,543.78%	18.95M 290.55%
other expenses
cost and expenses	376.86K -	2.43M 546.04%	10.10M 315.03%	24.31M 140.55%
operating expenses	376.86K -	2.43M 546.04%	10.10M 315.03%	24.31M 140.55%
interest expense	469.37K -	1.45M 209.59%	2.41K 99.83%	182.80K 7,472.58%
ebitda	-376.01K -	-2.33M 519.36%	-10.10M 333.88%	-24.11M 138.63%
operating income	-376.86K -	-2.43M 546.04%	-10.10M 315.03%	-24.31M 140.55%
depreciation and amortization	846 -	105.77K 12,402.84%		194.71K -
total other income expenses net	-469.17K -	-1.35M 187.30%	1.59M 217.86%	-11.91K 100.75%
income before tax	-846.03K -	-3.78M 347.10%	-8.52M 125.13%	-24.32M 185.57%
income tax expense	800 -	800 0%	6.00K 650.50%	20.78K 246.05%
net income	-846.83K -	-3.78M 346.77%	-8.52M 125.24%	-24.34M 185.61%
weighted average shs out	2.77M -	3.06M 10.50%	14.79M 383.10%	19.52M 31.95%
weighted average shs out dil	2.77M -	3.06M 10.50%	14.79M 383.10%	19.52M 31.95%
eps	-0.31 -	-1.24 300%	-0.58 53.23%	-1.25 115.52%
epsdiluted	-0.31 -	-1.24 300%	-0.58 53.23%	-1.25 115.52%

All numbers in USD (except ratios and percentages)